I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 18 studies | 29% ± 7% | |
| oligodendrocyte | 6 studies | 25% ± 8% | |
| microglial cell | 5 studies | 21% ± 5% | |
| interneuron | 5 studies | 30% ± 20% | |
| epithelial cell | 4 studies | 26% ± 5% | |
| type II pneumocyte | 4 studies | 22% ± 6% | |
| mast cell | 4 studies | 24% ± 7% | |
| erythrocyte | 4 studies | 46% ± 18% | |
| macrophage | 4 studies | 18% ± 3% | |
| endothelial cell | 3 studies | 26% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 4% | |
| ciliated cell | 3 studies | 20% ± 1% | |
| gamma-delta T cell | 3 studies | 22% ± 3% | |
| GABAergic neuron | 3 studies | 36% ± 12% | |
| glutamatergic neuron | 3 studies | 41% ± 16% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 10% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 30% ± 10% | |
| type I pneumocyte | 3 studies | 24% ± 6% |
